全文获取类型
收费全文 | 2102篇 |
免费 | 244篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 62篇 |
妇产科学 | 17篇 |
基础医学 | 262篇 |
口腔科学 | 33篇 |
临床医学 | 202篇 |
内科学 | 409篇 |
皮肤病学 | 150篇 |
神经病学 | 140篇 |
特种医学 | 147篇 |
外科学 | 353篇 |
综合类 | 56篇 |
现状与发展 | 20篇 |
一般理论 | 2篇 |
预防医学 | 108篇 |
眼科学 | 29篇 |
药学 | 102篇 |
中国医学 | 7篇 |
肿瘤学 | 246篇 |
出版年
2024年 | 7篇 |
2023年 | 44篇 |
2022年 | 22篇 |
2021年 | 38篇 |
2020年 | 44篇 |
2019年 | 27篇 |
2018年 | 83篇 |
2017年 | 61篇 |
2016年 | 62篇 |
2015年 | 71篇 |
2014年 | 73篇 |
2013年 | 110篇 |
2012年 | 85篇 |
2011年 | 91篇 |
2010年 | 82篇 |
2009年 | 100篇 |
2008年 | 90篇 |
2007年 | 88篇 |
2006年 | 91篇 |
2005年 | 75篇 |
2004年 | 61篇 |
2003年 | 51篇 |
2002年 | 61篇 |
2001年 | 60篇 |
2000年 | 41篇 |
1999年 | 52篇 |
1998年 | 41篇 |
1997年 | 44篇 |
1996年 | 59篇 |
1995年 | 42篇 |
1994年 | 26篇 |
1993年 | 31篇 |
1992年 | 28篇 |
1991年 | 32篇 |
1990年 | 34篇 |
1989年 | 41篇 |
1988年 | 36篇 |
1987年 | 32篇 |
1986年 | 33篇 |
1985年 | 24篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1973年 | 7篇 |
排序方式: 共有2369条查询结果,搜索用时 31 毫秒
1.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献2.
3.
4.
V Aerra M Kuduvalli AN Moloto AK Srinivasan AD Grayson BM Fabri AY Oo 《Journal of cardiothoracic surgery》2006,1(1):6-5
Background
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery. 相似文献5.
6.
Paul Wexberg MD BM Richard Pacher MD Suzanne Rdler MD Katharina Kiss MD Gilbert Beran MD Michael Grimm MD Gerald Maurer MD Dietmar Glogar MD FESC 《The Journal of heart and lung transplantation》2002,21(12):583-1263
BACKGROUND: Endothelin, a peptide with strong vasoconstrictive and mitogenic properties, has been found to increase after cardiac transplantation. We therefore assessed the association between its precursor peptide, big endothelin-1, and intimal hyperplasia and coronary flow reserve after heart transplantation. METHODS: Thirty-five patients without hemodynamically significant coronary artery disease after heart transplantation were investigated: Average peak flow velocity in the left anterior descending artery (LAD) was assessed by intracoronary Doppler at baseline as well as after injection of adenosine; coronary flow reserve was calculated as a ratio of both and was corrected for patient age and baseline average peak flow velocity. Lumen, intima + media and total vessel area were measured by intracoronary ultrasound. The plasma concentration of big endothelin-1 in venous blood was determined by radioimmunoassay. RESULTS: Patients with elevated big endothelin-1 levels (>2 fmol/ml) tended to have a decreased corrected coronary flow reserve (2.60 +/- 0.9 vs 3.21 +/- 1.0, p = 0.078). They also had a significantly larger intima + media area (5.82 +/- 2.9 vs 2.37 +/- 2.9 mm(2), p = 0.004) and total vessel area (18.36 +/- 5.8 vs 12.81 +/- 4.8 mm(2), p = 0.012) than those with normal plasma concentrations. CONCLUSIONS: Our study suggests an association between elevated big endothelin-1 plasma levels and the development of intimal hyperplasia and reduction of coronary flow reserve after cardiac transplantation. 相似文献
7.
8.
A randomized controlled trial of sedation in the critically ill 总被引:2,自引:0,他引:2
LYNN PARKINSON RSCN JULIE HUGHES RSCN REA GILL MSc IMOGEN BILLINGHAM BM FRCA JANE RATCLIFFE MB ChB FRCP & IMTI CHOONARA MD MRCP 《Paediatric anaesthesia》1997,7(5):405-510
A randomized controlled trial comparing: a) a combination of oral chloral hydrate and promethazine to b) a continuous intravenous midazolam infusion, for maintenance sedation in critically ill children, was carried out. The level of sedation was assessed four hourly using a specifically devized sedation scale. Forty-four children entered the study of whom two were subsequently excluded. The number of satisfactory assessments (desired and actual levels of sedation equal) was significantly greater in the chloral hydrate and promethazine group (Chi-squared P <0.01; confidence intervals of the difference 0.06 to 0.20). The number of assessments at level 5 on the sedation scale (patient restless/distressed) was significantly greater in the midazolam group (Chi-squared P <0.05). The total number of satisfactory assessments in the two groups were only 61 and 48% respectively, suggesting that sedation can be considerably improved. Chloral hydrate and promethazine are more effective than midazolam as maintenance sedation in critically ill children. It is possible to prospectively study the efficacy of sedative drugs in critically ill children. 相似文献
9.
10.